"Vibwife One" a New Medical Device to Support Delivering Women in Their Mobilization
NCT ID: NCT03443349
Last Updated: 2018-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2018-01-23
2018-11-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Although existing evidence is rare, some literature and historical reports have shown a positive impact of active mobilization during labor.
At time of rising epidural anesthesia rate, "Vibwife One" could be an interesting way to active mobilize those women to support the physiological birth process.
So far, the device has not yet been applied in delivering women. The investigators carry out a first safety study to assess the safety, to evaluate the comfort and the practicability for delivering women and medical staff of this new medical device.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The MOBY Study: Efficacy of Birth Mobility
NCT07052331
Demonstration of a New Device to Measure the Force of Delivering a Baby
NCT00964444
Potential of Vojta's Reflex Locomotion as a Pre/Induction Method for Uterine Activity: a Pilot Study
NCT06339528
The Swedish Birth Seat Trial
NCT01182038
Cervix Uteri "Resistance" Measurements
NCT03948932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* First five pregnant women use the device for 10 minutes. Each of them in a position and module proposed by the midwife with the agreement of the woman.
* Next 10 pregnant women use the device for 20 minutes. Again, position and module according to the decision of the midwife with the agreement of the woman.
* All the remaining pregnant women (35) use the device for 30 minutes. Position and module according to the decision of the midwife with the agreement of the woman.
During the intervention period, position and module might be changed once if required.
After the inclusion of all the 50 participants, each position and module has to be tested.
There will be a safety review board consisting of one physician, one midwife and a clinical expert midwife meeting after each group of pregnant women having used the device, evaluating the safety criteria according to predefined Adverse Device Effects and Adverse Events.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
* First five pregnant women use the device for 10 minutes. Each of them in a position and module proposed by the midwife with the agreement of the woman.
* Next 10 pregnant women use the device for 20 minutes. Again, position and module according to the decision of the midwife in agreement with the woman.
* All the remaining pregnant women (35) use the device for 30 minutes. Position and module proposed by the midwife with the agreement of the woman.
During the intervention period, position and module might be changed once if required.
There will be a safety review board meeting after each group of the pregnant women having used the device, checking the safety criteria according to predefined Adverse Device Effects and Adverse Events.
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Use of the medical Device: Vibwife One
The medical device will be used according to its market authorization.
Because it will be used for the first time in pregnant women, the following three step application procedure has been determined:
* First five pregnant women use the device for 10 minutes. Each of them in a position and module proposed by the midwife with the agreement of the woman.
* Next 10 pregnant women use the device for 20 minutes. Again, position and module according to the decision of the midwife with the agreement of the woman.
* All the remaining pregnant women (35) use the device for 30 minutes. Position and module according to the decision of the midwife with the agreement of the woman.
During the intervention period, position and module might be changed once if required.
Vibwife One
Vibwife One is a powered rotation bed intended to be used to assist in active mobilization of delivering women. "Vibwife One" imitates manual mobilization and position techniques. It is integrated in the mattress and fixed to the pelvis area of the birthing bed. "Vibwife One" can be used, when manual mobilization and position techniques are deemed appropriate.
The device with all its functions is controlled over a remote control.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vibwife One
Vibwife One is a powered rotation bed intended to be used to assist in active mobilization of delivering women. "Vibwife One" imitates manual mobilization and position techniques. It is integrated in the mattress and fixed to the pelvis area of the birthing bed. "Vibwife One" can be used, when manual mobilization and position techniques are deemed appropriate.
The device with all its functions is controlled over a remote control.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* German or English speaking
* Singleton healthy pregnancy
* Cephalic presentation
* ≥37th weeks of gestation
* 4cm - 9cm of dilatation
* Regular contractions
* Physiological cardiotocograph (CTG) 30 min pre-intervention
* Physiological blood pressure (111/66 - 139/89)
Exclusion Criteria
* Breech position
* Small for gestational age (\<10. Percentile)
* Fetal congenital abnormalities
* Placenta praevia
* Fetal distress
* Heavy vaginal bleeding during birth
* Maternal weight ≥ 135 kg
* Preeclampsia or HELLP
* Diabetes I and II / Gestational diabetes insulin dependent
* Spinal and back disorder (herniated disk / scoliosis)
* Hypertension (≥140/90 mmHg)
* Hypotension (Basic blood pressure in the third trimester -20%, if not available: ≤ 110/65 mmHg)
* No signed informed consent
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Clinical Trial Unit, University Hospital Basel, Switzerland
OTHER
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Irene Hösli, Prof. Dr. MD
Role: PRINCIPAL_INVESTIGATOR
Chief Physician Departement of Obstetrics and Antenatal care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lawrence A, Lewis L, Hofmeyr GJ, Styles C. Maternal positions and mobility during first stage labour. Cochrane Database Syst Rev. 2013 Aug 20;(8):CD003934. doi: 10.1002/14651858.CD003934.pub3.
Nieuwenhuijze MJ, de Jonge A, Korstjens I, Bude L, Lagro-Janssen TL. Influence on birthing positions affects women's sense of control in second stage of labour. Midwifery. 2013 Nov;29(11):e107-14. doi: 10.1016/j.midw.2012.12.007. Epub 2013 Feb 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-02085
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.